ATE398106T1 - Allylmercaptocaptoprilverbindungen und deren verwendungen - Google Patents
Allylmercaptocaptoprilverbindungen und deren verwendungenInfo
- Publication number
- ATE398106T1 ATE398106T1 AT02734587T AT02734587T ATE398106T1 AT E398106 T1 ATE398106 T1 AT E398106T1 AT 02734587 T AT02734587 T AT 02734587T AT 02734587 T AT02734587 T AT 02734587T AT E398106 T1 ATE398106 T1 AT E398106T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- allylmercaptocaptopril
- elevated
- allicin
- ace
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 abstract 1
- 206010014486 Elevated triglycerides Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 abstract 1
- 235000010081 allicin Nutrition 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29398901P | 2001-05-30 | 2001-05-30 | |
| US30441401P | 2001-07-12 | 2001-07-12 | |
| US31182901P | 2001-08-14 | 2001-08-14 | |
| US33496201P | 2001-12-04 | 2001-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE398106T1 true ATE398106T1 (de) | 2008-07-15 |
Family
ID=31499517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02734587T ATE398106T1 (de) | 2001-05-30 | 2002-05-30 | Allylmercaptocaptoprilverbindungen und deren verwendungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7241902B2 (de) |
| EP (1) | EP1414794B1 (de) |
| AT (1) | ATE398106T1 (de) |
| AU (1) | AU2002305744B2 (de) |
| CA (1) | CA2448896C (de) |
| DE (1) | DE60227078D1 (de) |
| IL (2) | IL159122A0 (de) |
| WO (1) | WO2002096871A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2610922A1 (en) * | 2005-06-13 | 2006-12-21 | Yeda Research And Development Co. Ltd. | Use of allylmercaptocaptopril for treating or preventing obesity and obesity related diseases |
| CA2637950A1 (en) * | 2006-01-25 | 2007-08-02 | Yeda Research And Development Co. Ltd. | A process for preparing allylmercaptocaptopril (cpssa) and related asymmetrical disulfides |
| US10383839B2 (en) | 2011-06-30 | 2019-08-20 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
| JP7442777B2 (ja) * | 2019-02-20 | 2024-03-05 | 池田食研株式会社 | 蛋白質加水分解物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4046889A (en) * | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
| US4347371A (en) * | 1978-12-30 | 1982-08-31 | Santen Pharmaceutical Co., Ltd. | Disulfide compounds |
| IL117934A0 (en) | 1996-04-16 | 1996-08-04 | Yeda Res & Dev | Continuous production of allicin |
-
2002
- 2002-05-30 IL IL15912202A patent/IL159122A0/xx unknown
- 2002-05-30 CA CA2448896A patent/CA2448896C/en not_active Expired - Fee Related
- 2002-05-30 AT AT02734587T patent/ATE398106T1/de not_active IP Right Cessation
- 2002-05-30 US US10/478,396 patent/US7241902B2/en not_active Expired - Fee Related
- 2002-05-30 AU AU2002305744A patent/AU2002305744B2/en not_active Ceased
- 2002-05-30 DE DE60227078T patent/DE60227078D1/de not_active Expired - Lifetime
- 2002-05-30 EP EP02734587A patent/EP1414794B1/de not_active Expired - Lifetime
- 2002-05-30 WO PCT/US2002/016964 patent/WO2002096871A1/en not_active Ceased
-
2003
- 2003-11-27 IL IL159122A patent/IL159122A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7241902B2 (en) | 2007-07-10 |
| AU2002305744B2 (en) | 2008-09-11 |
| DE60227078D1 (de) | 2008-07-24 |
| WO2002096871A8 (en) | 2004-03-25 |
| CA2448896C (en) | 2010-12-21 |
| US20040210065A1 (en) | 2004-10-21 |
| CA2448896A1 (en) | 2002-12-05 |
| EP1414794A4 (de) | 2005-04-06 |
| WO2002096871A1 (en) | 2002-12-05 |
| IL159122A0 (en) | 2004-05-12 |
| IL159122A (en) | 2010-12-30 |
| EP1414794B1 (de) | 2008-06-11 |
| EP1414794A1 (de) | 2004-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0413449A (pt) | compostos de quinoxalina | |
| NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
| ATE455092T1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| ATE384699T1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
| DE60134251D1 (de) | Verwendung von glp-2-peptiden | |
| DE60225385D1 (de) | Autentisches Document und dessen Herstellungsverfahren | |
| AU2002366083A8 (en) | Matrix for the production of tissue engineered ligaments, tendons and other tissue | |
| CY1109888T1 (el) | Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων | |
| MY142777A (en) | Substituted indole-o-glucosides | |
| UA87991C2 (en) | Substituted indole-o-glucosides | |
| BR0110573A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização do composto e processo para o tratamento profilático ou terapêutico e para a preparação do composto | |
| ATE529401T1 (de) | Aminocyclohexylether-verbindungen und deren verwendung | |
| ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
| GB0216001D0 (en) | Process and composition | |
| DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| ATE316084T1 (de) | Substituierte diazepan | |
| ATE405834T1 (de) | Bindungsoberfläche | |
| DE60007120D1 (de) | Isophosphoramide-senfgasanalogen und deren verwendung | |
| JP2004500380A5 (de) | ||
| ATE363890T1 (de) | Kationische polymerisate und deren verwendung in kosmetischen formulierungen | |
| DE60227078D1 (de) | Allylmercaptocaptoprilverbindungen und deren verwendungen | |
| BR0314139A (pt) | Derivados de 1,4-pirazina substituìdos | |
| DE60335610D1 (de) | Neoplasma-spezifische antikörper und deren verwendungen | |
| EA200401032A1 (ru) | Антиинфарктные молекулы | |
| ATE409191T1 (de) | 1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |